Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial.
Ahi M, Hamidi Farahani R, Basiri P, Karimi Rahjerdi A, Sheidaei A, Gohari K, Rahimi Z, Gholami F, Moradi M, Ghafoori Naeeni F, Saffar KN, Ghasemi S, Barati B, Moradi S, Monazah A, Pouranvari F, Forooghizadeh M.
Ahi M, et al. Among authors: barati b.
Vaccines (Basel). 2022 Oct 26;10(11):1800. doi: 10.3390/vaccines10111800.
Vaccines (Basel). 2022.
PMID: 36366308
Free PMC article.